Skip to NavigationSkip to content

News

A University of Cambridge research team has used human data to quantify the speed of different processes that lead to Alzheimer’s disease, and have...
A clinical trial with University of Liverpool researchers at The Clatterbridge Cancer Centre has shown great promise for an immunotherapy drug, which...
Renew Bioscience announced it has received Breakthrough Device Designation status from the FDA for the Cerezen® Device, a novel treatment for Mild...
A US study has revealed that the immunity received from COVID-19 vaccines is much stronger than that stimulated by infection with the virus itself,...
BioNet, a leading biotech company manufacturing genetically engineered vaccines, and Sartorius’ company BIA Separations, have announced the...
The Ontario-based London Health Sciences Centre’s transplant program is implementing a full COVID-19 vaccination requirement for future organ...
Biopharmaceutical company Dunad Therapeutics (Dunad) has annouced that it has entered into a strategic collaboration with Novartis, to develop orally...
Novartis have announced that the FDA approved Scemblix® (asciminib) for the treatment of chronic myeloid leukaemia (CML) in two distinct indications.
A COVID vaccine skin patch is on course for its first human trial by the University of Queensland in partnership with Vaxxas. It may prove more...
A US intelligence report saying it was plausible that COVID-19 originated in a Wuhan laboratory has been deemed unscientific and without credibility...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches